iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare iSpecimen to related companies based on the strength of its valuation, risk, analyst recommendations, earnings, institutional ownership, profitability and dividends. Insider & Institutional Ownership 11.6% […]
iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its rivals? We will compare iSpecimen to similar companies based on the strength of its institutional ownership, profitability, earnings, analyst recommendations, risk, dividends and valuation. Profitability This table compares iSpecimen and its […]
iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its rivals? We will compare iSpecimen to similar businesses based on the strength of its dividends, profitability, earnings, institutional ownership, risk, valuation and analyst recommendations. Profitability This table compares iSpecimen and its […]
iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare iSpecimen to similar businesses based on the strength of its earnings, analyst recommendations, profitability, institutional ownership, dividends, valuation and risk. Institutional and Insider Ownership 11.6% […]
iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare iSpecimen to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, valuation, profitability and earnings. Profitability This table compares iSpecimen […]